Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Lansdowne’s Ruddock Knighted for Philanthropy

Hedge fund manager Paul Ruddock, co-founder and chief executive of Lansdowne Partners was “knighted in the New Year’s honours list for his philanthropy and service to the arts,” reports the Financial Times. Sir Paul Ruddock has given half a million pounds to the Conservative Party and is chairman of the Victoria & Albert Museum (V&A). He also gave £5m to the V&A and £3 to the British Museum’s new medieval gallery.

Ruddock, who manages the $7.46-billion Lansdowne with Steve Heinz, “controversially took short positions in Northern Rock and HBOS at the height of the credit crunch.” Paul Ruddock

The Financial Times writes, “his hedge fund was among several criticized during the financial crisis of three years ago for shorting bank stocks.”

Financials, which were the worst performing stocks in 2011, still figure prominently in the Lansdowne portfolio. The fund’s third largest holding is Wells Fargo & Co New (WFC). It had $696.34 million invested in the company at the end of the third quarter, or roughly 9.33% of its portfolio, after increasing its stake by +3%. Lansdowne also has a significant position in Jpmorgan Chase & Co(JPM) after increasing its holding by +219% in the company during the third quarter. The fund has around 9.18% of its portfolio invested in JPM, in a stake valued at over $685.22 million. It is its fifth largest holding. Lansdowne also has significant positions in Citigroup Inc (C) and U S Bancorp Del (USB).

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!